SRPT Competitors
Sarepta Therapeutics, Inc.
$16.83
+$0.32(+1.94%)
50
Overall
60
Value
40
Tech
52
Quality
Market Cap
$1.74B
Volume
2.74M
52W Range
$14.68 - $24.68
Target Price
$21.35
SRPT competitors: GILD, NVAX, RNA, PTCT, ALNY. Sarepta Therapeutics, Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
SRPT Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| GILD Gilead Sciences, Inc. | $153.54 | $183.41B | $-0.47 | 2.12% | 73 |
| NVAX Novavax, Inc. | $12.63 | $2.11B | $-0.48 | - | 60 |
| RNA Atrium Therapeutics, Inc. | $7.68 | $132.57M | $-5.08 | - | 20 |
| PTCT PTC Therapeutics, Inc. | $59.67 | $5.00B | $1.19 | - | 45 |
| ALNY Alnylam Pharmaceuticals, Inc. | $224.15 | $29.95B | $6.68 | - | 34 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SRPT | $16.83 | +1.9% | 2.74M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Sarepta Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW